Elevated osteopontin levels in active relapsing-remitting multiple sclerosis.
about
Neurobehavioral burden of multiple sclerosis with nanotheranosticsOsteopontin and mucosal protectionCorrelation of circulating omentin-1 with bone mineral density in multiple sclerosis: the crosstalk between bone and adipose tissueMonitoring CSF proteome alterations in amyotrophic lateral sclerosis: obstacles and perspectives in translating a novel marker panel to the clinicEarly over expression of messenger RNA for multiple genes, including insulin, in the Pancreatic Lymph Nodes of NOD mice is associated with Islet AutoimmunityPlasma osteopontin levels in patients with head and neck cancer and cervix cancer are critically dependent on the choice of ELISA system.Predicting optimal response to B-cell depletion with rituximab in multiple sclerosis using CXCL13 index, magnetic resonance imaging and clinical measuresRole of osteopontin in amplification and perpetuation of rheumatoid synovitis.Cleavage of osteopontin by matrix metalloproteinase-12 modulates experimental autoimmune encephalomyelitis disease in C57BL/6 mice.Genetic associations in type I interferon related pathways with autoimmunityMetallothioneins as dynamic markers for brain disease in lysosomal disordersBlockade of osteopontin reduces alloreactive CD8+ T cell-mediated graft-versus-host diseasePlasma osteopontin predicts inflammatory bowel disease activities.Osteopontin expression in intratumoral astrocytes marks tumor progression in gliomas induced by prenatal exposure to N-ethyl-N-nitrosourea.Osteopontin mediates obesity-induced adipose tissue macrophage infiltration and insulin resistance in mice.The association between osteopontin gene polymorphisms, osteopontin expression and sarcoidosis.Increased cerebrospinal fluid osteopontin levels and its involvement in macrophage infiltration in neuromyelitis optica.Abrogation of T cell quiescence characterizes patients at high risk for multiple sclerosis after the initial neurological eventNuanced roles of cytokines in three major human brain disorders.Thrombin Cleavage of Osteopontin Modulates Its Activities in Human Cells In Vitro and Mouse Experimental Autoimmune Encephalomyelitis In Vivo.Systems biology approaches for the study of multiple sclerosis.A Journey in Science: The Privilege of Exploring the Brain and the Immune System.Chipping away at diagnostics for neurodegenerative diseasesOsteopontin Bridging Innate and Adaptive Immunity in Autoimmune Diseases.Discovery of novel disease-specific and membrane-associated candidate markers in a mouse model of multiple sclerosis.Pathogenic mechanisms and experimental models of multiple sclerosis.Intracellular osteopontin (iOPN) and immunity.Regulatory effects of IFN-beta on production of osteopontin and IL-17 by CD4+ T Cells in MS.Longitudinal Assessment of Transorbital Sonography, Visual Acuity, and Biomarkers for Inflammation and Axonal Injury in Optic Neuritis.Ancient viral protein enrages astrocytes in multiple sclerosis.Fluid biomarker and electrophysiological outcome measures for progressive MS trials.Osteopontin (OPN) as a CSF and blood biomarker for multiple sclerosis: A systematic review and meta-analysis.Up-regulation of osteopontin and alphaBeta-crystallin in the normal-appearing white matter of multiple sclerosis: an immunohistochemical study utilizing tissue microarrays.Evaluation of circulating osteopontin levels in an unselected cohort of patients with multiple sclerosis: relevance for biomarker development.Science is 1% inspiration and 99% biomarkers.Biomarkers
P2860
Q26778311-45DC8BCE-CE6A-4849-B0FE-C4E25CC4CA91Q28236080-4EE3EA67-76B9-4885-8269-08F47383E724Q28477087-8DFBDA43-22EE-4E7B-995D-DF3FE4F79B07Q28483618-ED0CC627-8521-45AA-8670-B1CCDCF81A59Q30874892-77F0015C-2964-4FB3-9BF7-D9CB8ADF49D4Q33254071-AE44AD91-6474-4D02-92EE-5ACD541DE475Q33692520-B9212630-9F2C-4A5A-8A53-E8B60119E3B7Q33700555-1DED75EC-4A37-4A3B-A3DC-2D9D0F8E5E7DQ34086999-753834A0-ACC0-4001-80D8-B33AB792C8AFQ34350182-0CEB12DE-643F-4BF0-B387-A8CAECDC8EE9Q34543984-C3B2F99A-89DE-4CE9-870D-1D9801370469Q34667586-1279E3F7-6F19-4543-800B-DBC8AE5A58BCQ34993236-A95FB9DE-D1B9-4A68-B910-613F995295CAQ35088334-9C8DC0A3-160D-4F67-B585-7CD4086B3CCAQ35970899-BB4880AB-C717-484F-9B95-74E826E9F997Q36295223-0C094457-8297-488D-A468-9228982D349DQ36323831-63A53D8C-6BD9-40AF-A528-E06025559E37Q36824348-2FE00322-F57D-4E6D-98F6-DED8E2B8CFCEQ36955568-020F2F15-CAC8-4B34-A245-7CBCC207AE06Q37127970-16B7EF9D-D4B1-478C-AAC7-64AAD0F56118Q37174203-44B87281-9F2F-4EFD-8408-56DBCA5FB696Q37217037-E567BCA5-8E67-4D8D-9D84-112585127270Q37366183-9D65C9AE-C3E2-4024-B2C2-54589ADB9538Q37549558-7F511B91-84B3-4654-AFA6-76F6288506C1Q37623616-CA8EC2EC-2F3E-4D53-AE61-275984BD7718Q37728003-7D044557-45C2-4E08-8121-C9487C321E95Q37817038-74E2799F-ECC0-4F52-8111-950F16CBD752Q39814049-AE66DC99-9588-4C41-8EE6-8A7F39E80126Q42728560-F2C21426-3B69-4CE8-8FFA-E48425D07FADQ47316965-A9ADE096-3358-4625-9BF3-649964DC57E4Q47638443-314CB9EE-F905-4FEF-95B7-EC032CB9F72CQ48217814-851005DE-6984-4CD8-AE7C-9549BA6B7FFDQ48892536-5054BB01-297D-4C68-88A8-4FE81B239706Q49074970-EBA325BA-36B4-41F8-A319-7A1681BD9227Q50984144-4004D756-938F-4D03-8846-8D8338243DA7Q57083573-C5426A6E-E526-44B8-A18E-F417A30C763E
P2860
Elevated osteopontin levels in active relapsing-remitting multiple sclerosis.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Elevated osteopontin levels in active relapsing-remitting multiple sclerosis.
@en
Elevated osteopontin levels in active relapsing-remitting multiple sclerosis.
@nl
type
label
Elevated osteopontin levels in active relapsing-remitting multiple sclerosis.
@en
Elevated osteopontin levels in active relapsing-remitting multiple sclerosis.
@nl
prefLabel
Elevated osteopontin levels in active relapsing-remitting multiple sclerosis.
@en
Elevated osteopontin levels in active relapsing-remitting multiple sclerosis.
@nl
P2093
P356
P1433
P1476
Elevated osteopontin levels in active relapsing-remitting multiple sclerosis.
@en
P2093
Chris H Polman
Lex Nagelkerken
Luba Lopatinskaya
Mario H J Vogt
Monique Smits
P304
P356
10.1002/ANA.10606
P577
2003-06-01T00:00:00Z